BioTeam Acquired by British n2 Group

BioTeam announced its acquisition today by British firm n² Group. BioTeam will be a US-based, independent business within n² Group. Financial details have not been disclosed.

“This was a unicorn deal,” Stan Gloss, BioTeam co-founder and fellow told Bio-IT World. “BioTeam can stay BioTeam and now we’re in the position to fund good academic research that advances science in our field.”

Ari Berman, BioTeam’s CEO, agreed. “BioTeam is a pretty unique company in a lot of good ways, and we’ve had a lot of opportunities for acquisition over the years, but [co-founders] Stan [Gloss] and Chris [Dagdigian] really held off in hopes that we might find somebody who would want to buy us because they like who we are...

Today's Sponsors

Today's Sponsor